Addendum to the note for guidance on antiarrhythmics on atrial fibrillation and atrial flutter

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCHMP/EWP/213056/2010
Published20/09/2010
Effective from01/02/2011
KeywordsAtrial fibrillation, rhythm control, rate control, cardioversion
DescriptionThis document is an addendum to the note for guidance on antiarrhythmics. It provides guidance for the evaluation of new medicinal products or drugs used in the antiarrhythmic treatment of atrial fibrillation.


Document history

First version

Current version

Adopted guideline

 

Draft guideline

 

Concept paper

In operation: 01/12/2011–present

 

Published: 24/07/2008

 

Published: 21/09/2006


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more